← All stocks

Vanda Pharmaceuticals Inc.

VNDA No buying or selling

CIK 0001347178 #3500 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Polymeropoulos Mihael Hristos

President and CEO

—

2,704,496

$22.36M

+44.5%

Birznieks Gunther

SVP, Business Development

—

494,197

$4.08M

+57.6%

Moran Kevin Patrick

SVP, CFO & Treasurer

—

411,380

$3.40M

+79.8%

Williams Timothy

SVP & General Counsel

—

377,450

$3.12M

+91.8%

Wijkstrom Joakim

SVP, Chief Marketing Officer

—

333,469

$2.76M

+156.9%

DUGAN RICHARD W

Director

—

219,054

$1.81M

+85.3%

Chrousos Phaedra

Director

—

164,950

$1.36M

+157.2%

Ward Anne Sempowski

Director

—

160,667

$1.33M

+168.5%

Honore Tage

Director

—

135,069

$1.12M

+110.2%

Mitchell Stephen Ray

Director

—

112,846

$932.77K

+126.3%

McGuire Daniel Patrick

SVP, GC and Secretary

—

109,982

$909.10K

+266.8%

Duncan Charles Cliff

Director

—

98,701

$815.85K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 19 Sep 2016